Pages that link to "Q36269758"
Jump to navigation
Jump to search
The following pages link to Human immunity to the meningococcus. II. Development of natural immunity (Q36269758):
Displaying 50 items.
- Vaccines for Gonorrhea: Can We Rise to the Challenge? (Q21131153) (← links)
- Prospects for vaccine prevention of meningococcal infection (Q24537338) (← links)
- Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine (Q24548670) (← links)
- Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice (Q24548847) (← links)
- Preventative strategies on meningococcal disease (Q24676339) (← links)
- Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners (Q24798614) (← links)
- Meningococcal Vaccinations (Q26752993) (← links)
- Meningococcal B vaccine and the vision of a meningitis free world (Q26770696) (← links)
- How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines (Q26782340) (← links)
- Will there ever be a universal Staphylococcus aureus vaccine? (Q26824837) (← links)
- Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease (Q27028161) (← links)
- MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine (Q28081147) (← links)
- Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity (Q28732187) (← links)
- Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine (Q28749695) (← links)
- Review of meningococcal vaccines with updates on immunization in adults (Q28828692) (← links)
- Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy (Q28972389) (← links)
- Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles (Q30227840) (← links)
- Emerging experience with meningococcal serogroup B protein vaccines (Q30234958) (← links)
- History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention (Q30249427) (← links)
- Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies (Q30442755) (← links)
- Infectious diseases associated with complement deficiencies (Q30450183) (← links)
- Structural characterization of the lipid A component of pathogenic Neisseria meningitidis (Q31120578) (← links)
- Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody (Q31155603) (← links)
- Association of a bacteriophage with meningococcal disease in young adults. (Q33391053) (← links)
- Towards the immunoproteome of Neisseria meningitidis (Q33468425) (← links)
- Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates (Q33595722) (← links)
- Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine (Q33597589) (← links)
- Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers (Q33601899) (← links)
- Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage (Q33603065) (← links)
- Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vacc (Q33613482) (← links)
- Meningococcal infections. (Q33615836) (← links)
- Bactericidal and bacteriolytic activity of serum against gram-negative bacteria (Q33627395) (← links)
- Epidemiological profile of meningococcal disease in the United States (Q33648635) (← links)
- Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. (Q33703560) (← links)
- Prophylaxis of bacterial meningitis (Q33724705) (← links)
- Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine. (Q33767903) (← links)
- The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum (Q33769638) (← links)
- Update on meningococcal disease with emphasis on pathogenesis and clinical management (Q33812435) (← links)
- Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage (Q33840768) (← links)
- Humoral immune responses to Neisseria meningitidis in children (Q33867340) (← links)
- Update on Haemophilus influenzae serotype b and meningococcal vaccines (Q33889550) (← links)
- Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis (Q33946852) (← links)
- Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine (Q33959308) (← links)
- The oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies (Q33963027) (← links)
- Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides (Q33992223) (← links)
- Importance of complement source in measuring meningococcal bactericidal titers (Q33999159) (← links)
- Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein. (Q34001933) (← links)
- Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine (Q34003052) (← links)
- Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci (Q34007787) (← links)
- Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model (Q34033214) (← links)